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There is considerable interest in developing drugs and probes targeted to mitochondria
in order to understand and treat the many pathologies associated with mitochondrial
dysfunction. The large membrane potential, negative inside, across the mitochondrial
inner membrane enables delivery of molecules conjugated to lipophilic phosphonium
cations to the organelle. Due to their combination of charge and hydrophobicity,
quaternary triarylphosphonium cations rapidly cross biological membranes without the
requirement for a carrier. Their extent of uptake is determined by the magnitude
of the mitochondrial membrane potential, as described by the Nernst equation. To
further enhance this uptake here we explored whether incorporation of a carboxylic
acid into a quaternary triarylphosphonium cation would enhance its mitochondrial
uptake in response to both the membrane potential and the mitochondrial pH gradient
(alkaline inside). Accumulation of arylpropionic acid derivatives depended on both the
membrane potential and the pH gradient. However, acetic or benzoic derivatives did
not accumulate, due to their lowered pKa. Surprisingly, despite not being taken up by
mitochondria, the phenylacetic or phenylbenzoic derivatives were not retained within
mitochondria when generated within the mitochondrial matrix by hydrolysis of their
cognate esters. Computational studies, supported by crystallography, showed that these
molecules passed through the hydrophobic core of mitochondrial inner membrane as a
neutral dimer. This finding extends our understanding of the mechanisms of membrane
permeation of lipophilic cations and suggests future strategies to enhance drug and
probe delivery to mitochondria.
Keywords: mitochondria, phosphonium, mitochondria-targeting, membrane permeation, membrane potential,
pH gradient, computational chemistry
INTRODUCTION
Mitochondrial dysfunction contributes to a wide range of pathologies, consequently they are an
important therapeutic target (Nunnari and Suomalainen, 2012; Gorman et al., 2016; Murphy and
Hartley, 2018). Furthermore, the delivery of probe molecules to the organelle in vivo is essential
in understanding how mitochondrial dysfunction arises (Yousif et al., 2009; Smith et al., 2012;
Logan et al., 2014; Jean et al., 2016). There are a number of strategies to deliver molecules to
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mitochondria in vivo, with conjugation to the
alkyltriphenylphosphonium (TPP) cation being the most
widespread (Smith et al., 2003, 2012; Yousif et al., 2009). TPP
is used because it readily crosses biological membranes without
the requirement for a protein carrier, and is chemically tractable
making it easy to introduce synthetically into the molecule to be
targeted (Smith et al., 2011, 2012), as well as having a good safety
and toxicity profile. An important aspect of the TPP targeting
system is that its positive charge and the large mitochondrial
membrane potential lead to these molecules accumulating
∼1,000-fold within energized mitochondria, as described by
the Nernst equation (Ross et al., 2006; Smith et al., 2011). Even
so, improving mitochondria-targeting head groups to enhance
mitochondrial accumulation would lead to improved therapies
and probes.
To develop an improved mitochondria-targeting head group,
we started from the finding that a TPP cation conjugated to a long
alkyl chain carboxylic acid 1 accumulates within mitochondria
to a greater extent than related compounds without an acid
moiety (Figure 1) (Finichiu et al., 2013). This greater uptake
occurs because of the equilibrium between the protonated (1)
and deprotonated forms (2) determined by the pKa of the
carboxylic acid (∼4.9) (Kanicky and Shah, 2003). The higher
pH of the mitochondrial matrix (∼8) relative to the cytosol
(∼7.2) and the inability of the zwitterionic TPP carboxylate 2 to
cross the mitochondrial inner membrane means that the overall
accumulation of the molecule is enhanced 4–10-fold compared
to a comparable TPP without a carboxylic acid (Finichiu et al.,
2013). Hence, we set out to develop a generic TPP-carboxylic
acid targeting group so as to enhance mitochondrial uptake 4–
10-fold over current TPP groups (Figure 1). The simplest way
to do this is to incorporate a carboxylic acid group on one
of the TPP phenyls. Both protonated and deprotonated forms
of the carboxylic acid would be present in a ratio depending
on the pKa of the acid and the local pH (Figure 1). Only the
protonated form of the TPP-carboxylic acid targeting group
FIGURE 1 | Enhanced mitochondrial uptake by a TPP cation linked to a carboxylic acid. Model showing how a TPP long chain carboxylic acid 1 crosses the
mitochondrial inner membrane and accumulates within the mitochondrial matrix in its zwitterionic form 2 due to the higher pH (∼ 8) in mitochondria compared to that
in the cytosol (∼ 7.2). IMM, inner mitochondrial membrane; IMS, intermembrane space.
should cross the mitochondrial membrane and once within
the matrix, the higher pH should increase accumulation of the
membrane-impermeant deprotonated form. Thus, this approach
should generate a generic TPP-carboxylic acid targeting group
to increase the delivery of the same cargo targeted with a TPP
group (Figure 1). Furthermore, this combined TPP-carboxylic
acid targeting group could easily be attached to any cargo using
a simple phosphine-carboxylic acid precursor. Here we set out
to develop such a generic TPP-carboxylic acid targeting group to
enhance the delivery of drugs and probes tomitochondria in vivo.
MATERIALS AND METHODS
Synthetic Chemistry
The test compounds 3–19 were prepared as shown in Scheme 1.
Phosphines 20 and 21 were alkylated with iodomethane, 1-
bromohexane, or 1-bromododecane to give the corresponding
salts 3–8 (Scheme 1). Carboxylic acids 3, 4, 7 were converted
into the corresponding ethyl esters 12, 13, and 15 by stirring
in ethanol with catalytic concentrated sulfuric acid. The
trifluoroethyl ester 19 was prepared from carboxylic acid 7
in a similar way using trifluoroethanol as solvent. However,
a better approach to trifluoroethyl esters was to esterify the
carboxylic acid group of the parent phosphines 20 and 21 with
trifluoroethanol using diisopropylcarbodiimide (DIC) coupling
with dimethylaminopyridine (DMAP) as a nucleophilic catalyst
to give the corresponding esters 23 and 24, and then alkylate the
phosphine to give the phosphonium salts 16–18. Ethyl ester 14
was prepared in a similar way using dicyclohexylcarbodiimide
(DCC) coupling to make ester 22 followed by alkylation
with iodomethane. The synthesis of the phenylpropionic acid
derivatives 9–11 began with the preparation of iodoarene 25
by the method of (Qin et al., 2015) and protection of the acid
as ester 26 (Scheme 2). Adapting the procedure reported by
(Dydio et al., 2014), which we had used to prepare phosphine
21, iodoarene 26 was cross-coupled with diphenylphosphine and
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SCHEME 1 | Synthesis of test phosphonium salts 3–8 and 12–19.
then alkylated in situ with iodomethane, 1-bromobutane, or 1-
bromohexane to give the corresponding phosphonium salts 27–
29. Acid-catalyzed hydrolysis then gave the phosphonium salts
9–11. The details of the synthetic procedures are described in the
Supplemental Information.
Biology-Methods
Animals
All procedures were carried out in accordance with the UK
Animals (Scientific Procedures) Act 1986 and the University of
Cambridge Animal Welfare Policy. Female Wistar rats (typically
6–10 weeks old, weighing ∼200 g, Charles River Laboratories,
UK) were housed in pathogen-free facilities at 21 ± 2◦C,
humidity 57 ± 5% with a 12 h light/dark cycle and laboratory
chow and water were available ad libitum.
Isolation of Rat Liver and Heart Mitochondria
Rats were killed by stunning and cervical dislocation and the liver
or heart rapidly excised and transferred to ice cold mitochondrial
isolation buffer. Mitochondria were isolated from rat liver tissue
by differential centrifugation in STE buffer [250mM sucrose,
5mM Tris, 1mM ethyleneglycol-bis(β-aminoethylether)-N, N,
N’, N’-tetraacetic acid (EGTA) (pH 7.4 at 4◦C, adjusted with
HCl)] (Chappell and Hansford, 1972). The liver was washed in
ice-cold STE, chopped finely, rinsed in STE and homogenized
5–8 times using a loose PTFE pestle in a 55ml Potter-Elvehjem
tissue grinder (Wheaton, USA) and then with a tight pestle. The
homogenate was centrifuged (1,000 × g, 3min, 4◦C), the pellets
were discarded, and the supernatants centrifuged (10,000 x g,
10min, 4◦C). The supernatant was discarded and the pellet was
resuspended and centrifuged again (10,000 × g, 10min, 4◦C).
SCHEME 2 | Synthesis of test phosphonium salts 9–11.
The final mitochondria pellet was resuspended in ∼5mL STE
buffer, kept in ice and used within 4 h.
Rat hearts were washed in ice-cold STEB buffer [STE
buffer supplemented with 0.1% (ws/v) fatty-acid free bovine
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serum albumin (BSA)], chopped finely, washed again and then
homogenized 5–8 times using a loose PTFE pestle in a 55mL
Potter-Elvehjem tissue grinder (Wheaton, USA) and then a tight
pestle with roughly 8 strokes. The homogenate was centrifuged
(700× g, 5min, 4◦C) and the supernatant was decanted through
two layers of a pre-wetted muslin into new centrifuge tubes.
The pellet was resuspended and centrifuged again (700 × g,
5min, 4◦C). This supernatant was also decanted through muslin
and the combined supernatants centrifuged (10,000 × g, 10min,
4◦C). The mitochondrial pellet was resuspended in STEB and
centrifuged again (10,000 × g, 10min, 4◦C). The mitochondrial
pellet was resuspended in STE without BSA (∼300 µL per heart),
kept on ice and used within 4 h. The protein concentration of the
mitochondrial suspensions was determined using the BCA assay
using BSA as a standard (Thermo Fisher Scientific, UK).
Reversed Phase-High Performance Liquid
Chromatography (RP-HPLC)
For most RP-HPLC experiments, the stationary phase used was a
C18 column (Jupiter 300 Å, Phenomenex) with a Widepore C18
guard column (Phenomenex). The column was connected to a
321 pump, a UV/Vis 151 system (Gilson, UK), a RIC20 Remote
Controlled Chilling/Heating Dry bath (Torrey Pine Scientific)
and a GX-241 liquid handler (Gilson) with Trilution LC 3.0
software (Gilson). The mobile phase was a gradient of water
+ 0.1% (v/v) trifluoroacetic acid (TFA) (HPLC buffer A) and
acetonitrile [HPLC grade acetonitrile (Fisher Scientific, UK)] +
0.1% (v/v) TFA (HPLC buffer B) at a flow rate of 1 mL/min.
Samples were prepared in 1mL, containing 25% acetonitrile
+ 0.1% (v/v) TFA. Prior to analysis, they were filtered under
vacuum using Protein Precipitation Plates (Porvair, 100µm pre-
filter frit, < 10µm secondary frit). The filtrate was transferred
to centrifuge tubes and placed in the chilled sample holder. 800
µL of sample were loaded into a 2mL sample loop and injected
onto the column for analysis. Compounds were eluted using the
following gradient: 0–2 min: 5% buffer B, 2–17 min: 5-100%
buffer B, 17–19 min: 100% buffer B, 19–22 min: 100-5% buffer
B. For some RP-HPLC experiments samples were prepared in
850 µL, containing 20% acetonitrile +0.1% (v/v) TFA. This was
transferred to centrifuge tubes and placed in the chilled sample
holder. 800 µL of sample were loaded into a 2mL sample loop
and injected onto the column for analysis. Compounds were
eluted using the following gradient: 0–2 min: 5% buffer B, 2–4
min: 55% buffer B, 4–16 min: 70% buffer B, 16–18 min: 70-100%
buffer B, 18–21 min: 100% buffer B, 21–23 min: 100–5% buffer
B. All samples were detected at 220 nm and peaks identified by
comparing the retention times of the known standards.
Mitochondrial Incubation of Compounds
Rat liver or heart mitochondria (0.5mg protein/mL) were
incubated in 2mL KCl buffer (120mM KCl, 10mM HEPES,
1mM EGTA, adjusted with KOH to pH 7.2, 37◦C) supplemented
with compound and internal standard (5µM each, unless
otherwise stated) in a shaking heat block (37◦C, 1,000 rpm).
Mitochondria were energized with succinate/rotenone (10
mM/10µM) or glutamate/malate (10mM each). To abolish
the mitochondrial proton motive force either FCCP (1µM),
or a mixture of oligomycin, antimycin A and valinomycin
(OAV) (5µg/mL, 100 nM, 1 nM, respectively) were used. After
the appropriate incubation time, the mitochondrial suspensions
were rapidly cooled on ice and the mitochondria pelleted by
centrifugation (10,000× g, 5min, 4◦C). The mitochondrial pellet
was dried by aspirating the supernatant, snap frozen and stored
at−80◦C until RP-HPLC analysis. For this, the pellet was thawed
and extracted by resuspension in 250 µL HPLC buffer B with
vortexing, and then centrifuged (16,000 × g, 10min, 4◦C). The
resulting supernatant was removed and 750 µL HPLC buffer A
was added.
Mitochondrial Respiration Assay
Respiration of isolated mitochondria was assessed using the
Oroboros Oxygraph-2K (O2K) high resolution respirometer
(Oroboros Instruments, Austria), equipped with two stirred
(200 rpm), and temperature controlled (37◦C) chambers. Before
starting experiments, 2mL KCl buffer was left to equilibrate
for approximately 1 h and the Oroboros was calibrated. Rat
liver mitochondria (2mg protein/mL) were then added to the
chamber with glutamate and malate (10mM each). The lid
was closed, and respiration assessed. Compounds were added
in increasing concentrations using gastight syringes (Hamilton
Robotics, UK), with equal volumes of control compound being
used in parallel experiments. Additions did not exceed 10 µL
per addition.
QUANTUM-CHEMICAL CALCULATIONS
Computational Details
Free energies of transfer and of ion-pairing/dimerisation were
calculated using density-functional theory (DFT) with the TPSS
exchange-correlation functional (Tao et al., 2003) (which is a pure
meta-GGA functional) supplemented by Grimme’s D3 correction
(Grimme et al., 2010, 2011) to account for dispersive interactions.
Structures and vibrational frequencies were calculated with the
def2-SVP (cations) and def2-SVP+ (ion pairs and anions) basis
sets, final energies with def2-TZVP+ in all cases (Weigend and
Ahlrichs, 2005; Weigend, 2006). The “+” indicates augmentation
of the published sets with one diffuse Gaussian function per
valence angular momentum on all atoms; the exponents of the
diffuse functions were derived such as to form a geometric series
with the existing two outermost functions (even-tempered).
Structure optimisations and frequency calculations were
performed with Turbomole 6.4 (Ahlrichs et al., 1989; Häser
and Ahlrichs, 1989; Treutler and Ahlrichs, 1995; von Arnim
and Ahlrichs, 1998, 1999), making use of the efficient MARI-J
technique (Sierka et al., 2003). SCF energies were converged to
10−8 Eh; structures to 10−6 Eh in the energy and 10−4 Eh a0−1
in the gradient. The COSMO continuum solvent model (Klamt
and Schüürmann, 1993; Klamt and Jonas, 1996) was applied
throughout, with default solvation radii and relative permittivity
εr = 78.3553 and refractive index n = 1.3334 for water and
εr = 1.8819, n = 1.3749 for hexane. Frequencies were obtained
by numerical differentiation (NumForce), using only the “slow”
component of solvent polarization (Klamt, 1996). All structures
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were confirmed by the absence of imaginary frequencies to be
minima on the potential-energy surface in the respective solvent.
Final energies were calculated with Gaussian 09 (Frisch et al.,
2013), using the SMD solvation model, which combines the IEF-
PCM polarisable continuum model for electrostatic solvation
(Tomasi et al., 2005) with the SMD non-electrostatic terms
(Marenich et al., 2009). The same values of εr and n were used
as above (which are G09 default values, noting that n = ε∞1/2).
Default solvation radii were used, except for Cl, whose solvation
radius was reduced from 2.38 Å to 1.8 Å in order to reproduce
better the experimental free energy of hydration (Hünenberger
and Reif, 2011) of Cl−, 1solvG∗(Cl−, aq) = −316.55 kJ mol−1;
the default radius yielded −271 kJ mol−1, the adjusted radius
−307 kJ mol−1. The solvation radius of Na was similarly reduced
from 2.27 Å to 1.6 Å; experimental 1solvG∗(Cl−, aq) = −427.41
kJ mol−1, calculated using default radius: −302 kJ mol−1,
calculated using adjusted radius:−429 kJ mol−1.
The thermal contributions to the free energy (including
the zero-point vibrational energy) were calculated according
to the standard ideal-gas/rigid-rotor/harmonic-oscillator
approximation at T = 298.15K, p◦ = 100 kPa. Frequencies
were not scaled; however, to avoid spurious large entropy
contributions from low-frequency vibrational modes, for which
the harmonic-oscillator approximation is unreliable, frequencies
below 100 cm−1 were raised (Ribeiro et al., 2011) to 100 cm−1.
pKa values were calculated from free energies obtained at the
M06-2X/def2-TZVP+ level (Zhao and Truhlar, 2008) using the
SMD continuum model for water in Gaussian 09. Frequencies
were scaled (Alecu et al., 2010; Kanchanakungwankul et al., 2018)
by a factor of 0.972 and raised (Ribeiro et al., 2011) to≥100 cm−1
using the GoodVibes program (Funes-Ardoiz and Paton, 2018)
for the calculation of free energies. The pKa value of an acid HA
was then computed with respect to a reference acid HRef with
experimentally known pKa as follows:
pKa(HA) = lg(e)1Ga(HA)/(RT)+ pKa
expt(HRef)− pKa
calc(HRef)
where lg(e) is the decadic logarithm of Euler’s number,1Ga(HA)
= G∗(A−) – G∗(HA), and pKacalc(HRef)= lg(e)1Ga(HRef).
Choice of Standard States
We express all thermodynamic quantities in solution with
reference to a fixed-solute equal-concentrations standard state
as defined by Ben-Naim (Ben-Naim, 1987, 1992), indicated by
∗, with a concentration of c∗ = 1mol L−1. The usual gas-phase
standard state with p◦ = 100 kPa is indicated by ◦; the standard
temperature is T = 298.15K in both cases. The free energy of
solute S in solution contains a liberational term, which replaces
the gas-phase translational free energy. In the ∗ standard, these
terms are exactly equal,
G∗lib(S, sln) = G
∗
trans(S, g).
The liberational free energy can therefore be calculated as
G∗lib(S, sln) = G
◦
trans(S, g)+1G
◦→∗,
where 1G◦→∗ = RT ln(RTc∗/p◦) = 8.0 kJ mol−1 is the
conversion between standard states, associated with the
isothermal compression of 1mol of ideal gas from its
concentration at p◦ to c∗. For a process in solution where
the number of particles changes, e.g., ion-pairing, the free-energy
change 1Gsln∗ therefore includes a term 1G◦→∗ × 6ivi, where
νi are the (signed) stoichiometric coefficients of reactants
and products.
RESULTS AND DISCUSSION
Enhanced Mitochondria-Targeting With a
Triphenylphosphonium Carboxylic Acid
To develop an enhanced mitochondria-targeting head group,
we first made a series of alkyltriphenylphosphonium (TPP)
salts with a carboxylic acid group on one phenyl group
para to the phosphorus (Figure 2A). The uptake of these
compounds by energized mitochondria, which will have a large
membrane potential, was studied alongside TPP-containing
internal standards (IS). Uptake of the IS confirmed that the
test compound did not significantly disrupt mitochondrial
membrane potential and showed that the mitochondria
continued to respond as expected to different additives known
to affect the membrane potential. Energized mitochondria
were incubated with carboxylic acid 3 and IS and uptake of
the compounds into mitochondria measured by RP-HPLC
(Figure 2B) and quantified (Figure 2C). The IS was taken up by
energized mitochondria and abolishing the membrane potential
with the uncoupler FCCP (Nicholls and Ferguson, 2013),
blocked this uptake (Figures 2B,C). However, carboxylic acid
3 was not taken up by energized mitochondria (Figures 2B,C).
A hydrophobicity threshold is required for mitochondrial
uptake of alkylTPP molecules (Ross et al., 2006; Finichiu
et al., 2015; Hu et al., 2017), but when hydrophobicity was
increased by replacing the methyl (3) with a hexyl group
(4) there was still no mitochondrial uptake compared to IS
(Figure 2D). Incorporating the more hydrophobic dodecyl
group (5) led to extensive adsorption to mitochondria that was
unaffected by uncoupling with FCCP (Figure 2E). Extending
incubation time to 15min did not lead to uptake (data not
shown). We conclude that alkylTPP salts with a carboxylic
acid on one of the phenyl groups of TPP are not taken up by
energized mitochondria.
The pKa values of 3–5 may have influenced mitochondrial
uptake. The enhanced mitochondrial uptake reported previously
was for a carboxylic acid attached to a TPP via an undecyl
chain (1) with a pKa∼4.9 (Finichiu et al., 2013). Stabilization
of the deprotonated form by the phenyl and the phosphonium
cation in 3–5 may lower the pKa, decreasing the proportion
in the membrane permeant, protonated form (Figure 1). The
pKa of 3 was determined computationally by reference to
experimental pKa values for benzoic acid and phenylacetic
acid, giving a pKa of 2.5 ± 0.1 (Table 1). At intracellular
pH (7.2) the TPP undecylcarboxylic acid (pKa ∼4.9) (Kanicky
and Shah, 2003) would be ∼0.5% in the protonated form,
compared to 0.002% for 3, ∼300-fold lower. We next distanced
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TABLE 1 | Calculated pKa values of carboxylic acids 3, 6, and 9, with reference to
benzoic acid and phenylacetic acid.
Compound pKa
PhCOOH ref PhCH2COOH
ref
Experiment
(Rumble et al.,
2018)
PhCOOH 4.204 4.4 4.204
PhCH2COOH 4.1 4.31 4.31
TPMP+-COOH (3) 2.4 2.6
TPMP+-CH2COOH (6) 2.6 2.8
TPMP+-CH2CH2COOH (9) 5.1 5.3
Reference values are printed in italics.
the acid group from the phenyl and phosphonium, to make
phenylacetic and phenylpropionic derivatives with a range of
hydrophobicities (6–11) (Figure 3A). The pKa values of 6 and
9 were then computationally determined by reference to the
experimental values for benzoic and phenylacetic acid, yielding
pKa values of 2.7 ± 0.1 (6) and 5.2 ± 0.1 (9) (Table 1).
So, if 3 was excluded from mitochondria by its low pKa
then 6–8 should also be excluded, while 9–11 should be
accumulated. The phenylacetic acid derivatives 6 and 7 showed
no uncoupler-sensitive mitochondrial uptake (Figures 3B,C),
while the more hydrophobic 8 adsorbed to mitochondria
independently of membrane potential (Figure 3D). For the
propionic acid derivatives (9–11) we made methyl, butyl and
hexyl versions as the hydrophobicity of the dodecyl compounds
FIGURE 2 | Mitochondrial uptake of TPP benzoic acids. (A) Structure of TPP benzoic acids 3, 4, and 5. (B) Liver mitochondria (0.5mg protein/ml) supplemented with
succinate and rotenone, were incubated with 3 and an internal standard (IS; isoamyl TPP) at 37◦C for 5min ± FCCP. Mitochondria were pelleted by centrifugation and
extracted for analysis by RP-HPLC. (C–E) Quantification of mitochondrial uptake of 3, 4, and 5. (C), 3, IS = isoamyl TPP; (D), 4, IS = TPMP; (E), 5, IS = propylTPP).
Data are mean ± S.E.M. of peak areas from three biological replicates.
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FIGURE 3 | Mitochondrial uptake of TPP acetic and propionic acids. (A) Structure of TPP carboxylic acids 6–11. (B–G) Quantification of mitochondrial uptake of
6–11. Mitochondria were incubated as described in Figure 2B, except for the indicated alterations. (B), 6, IS = isoamylTPP; (C), 7, IS = TPMP; (D), 8, IS = TPMP;
(E), 9 (10µM), IS = propylTPP (2.5µM), and data shown are for incubation with heart mitochondria. The same result was obtained with liver mitochondria; (F), 10,
(10µM), IS = TPMP (5µM), and data shown are for liver mitochondria. The same result was obtained with heart mitochondria; (G), 11, (20µM) IS = TPMP (2.5µM).
Data shown are for incubation with heart mitochondria. The same result was obtained with liver mitochondria. Data are mean ± S.E.M. of RP-HPLC peak areas from
three biological replicates except for panel G, where the +FCCP data are mean ± range (n = 2).
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5 and 8 made mitochondrial experiments uninformative. We
found that 9–11 were all taken up by energized mitochondria,
but not by uncoupled mitochondria (Figures 3E–G). Thus, the
lack of mitochondrial uptake of the benzoic and phenylacetic
derivatives was due to their low pKa. Note that the accumulation
of the IS were significantly higher than the carboxylic
acids 9-11 (hence two Y-axes are used in Figures), even
when the least lipophilic TPP-derivative, TPMP, was used as
IS (Figure 3F).
We next assessed whether the mitochondrial uptake of the
propionic acid TPP derivatives was enhanced by the pH gradient
as shown in Figure 1. To do this we incubated 10 and TPMPwith
energized mitochondria and measured the accumulation ratio
(ACR), that is the amount of the compound accumulated within
mitochondria, normalized to the amount in the medium outside
the mitochondria (Finichiu et al., 2013). The ACRs for 10 and
TPMP were both substantial and were decreased by uncoupling
FIGURE 4 | Effect of the pH gradient on mitochondrial uptake of TPP
propionic acids. (A) Liver mitochondria (1mg protein in 1ml) were incubated
as described in Figure 2B, with 5µM 10 and TPMP, with FCCP or nigericin as
indicated. Then the mitochondria were pelleted and the amounts of 10 and
TPMP in the supernatant and pellets determined by RP-HPLC and used to
calculate the ACRs for 10 and TPMP. (B) The ratios of the ACRs for 10 and
TPMP were determined in the absence and presence of nigericin. Data are
mean ± S.E.M. based on RP-HPLC peak areas from 4 to 5 replicates. *p <
0.05, ***p < 0.001 by Student’s unpaired t-test.
with FCCP (Figure 4A). When the K+/H+ exchanger nigericin
(Nicholls and Ferguson, 2013) was added to abolish the pH
gradient and thereby increase the membrane potential, the ACR
for TPMP increased as expected, but that for 10 stayed about the
same (Figure 4A). This behavior is consistent with the uptake of
10 being in response to both the membrane potential and the
pH gradient, while that of TPMP is solely determined by the
membrane potential (Finichiu et al., 2013). Hence, the addition
of nigericin will increase the uptake of TPMP due to the elevation
of the membrane potential, but for 10 the abolition of the pH
gradient will counteract any increased uptake due to an elevated
membrane potential. To confirm this, we next compared the
ratio of the ACRs for 10 and TPMP in the presence and absence
of nigericin, which showed that nigericin lowered the ratio of
these ACRs (Figure 4B). We conclude that the uptake of 10 into
mitochondria is driven by both the membrane potential and the
pH gradient as anticipated in Figure 1.
Utilizing TPP Carboxylic Ester Head
Groups to Retain Compounds Within
Mitochondria
The TPP compounds containing benzoic and phenylacetic acid
derivatives were not taken up by energized mitochondria because
their low pKa prevented passage across the mitochondrial
inner membrane. However, their esters should be taken up
with subsequent enzymatic hydrolysis within mitochondria then
generating the membrane-impermeant acids (Figure 5). This
would enable the prolonged delivery of drugs and probes to the
mitochondrial matrix where enzymatic hydrolysis generates a
TPP carboxylic acid “locked” within the mitochondrial matrix
(Figure 5). To test this possibility wemade ethyl esters (12–15) of
the membrane impermeant TPP benzoic and phenylacetic acids
while we also modulated the lipophilicity with methyl and hexyl
alkyl groups (Figure 6A).
The esters 12–15 were all taken up by energized liver
mitochondria and partially hydrolysed within mitochondria
(Figures 6B–E), with the benzoate esters 12 and 13 hydrolysing
faster than the phenylacetate esters 14 and 15. To further
accelerate ester hydrolysis we next made esters (16–19)
incorporating the electron-withdrawing trifluoroethyl group
(Figure 6F). Trifluoroethyl esters of phenylacetic acid are
known to be hydrolysed 40 times more quickly than ethyl
esters by the archetypical esterase, pig liver esterase (Barton
et al., 1994). All these esters 16–19 were taken up into
energized mitochondria and almost completely hydrolysed
(Figures 6G–J). The methyl derivatives 12, 16, and 18 were
also taken up by energized heart mitochondria where the lower
esterase activity enabled both acid and ester to be detected
(Figures 6K–M).
Thus, the ethyl and trifluoroethyl esters 12–19 are
accumulated by energized mitochondria and are there
hydrolysed within the matrix to the corresponding acid.
To see if the acid was retained in the matrix, we incubated
mitochondria with the esters for 5min to generate the acid
within the matrix, and then abolished the membrane potential
with FCCP. As expected, the IS and the remaining ester
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FIGURE 5 | Model of ester uptake and hydrolysis within mitochondria. The lipophilic cations of the esters 12–19 readily cross the mitochondrial inner membrane and
are accumulated in the matrix in response to the membrane potential. Within mitochondria, hydrolysis forms the cations of the corresponding carboxylic acids, which
exist almost exclusively as their highly charged zwitterions at pH 8.0. The zwitterions should be unable to cross the mitochondrial inner membrane and so be trapped
within the mitochondrial matrix. IMM, inner mitochondrial membrane; IMS, intermembrane space.
were lost from the uncoupled mitochondria (Figures 7A–D).
However, for 12 and 18 the acid accumulated within liver or
heart mitochondria was also lost upon uncoupling to similar
extents as the IS and ester (Figures 7A–D). Esters 13–17 and
19 showed similar behavior (data not shown). FCCP is a
lipophilic anion, so to eliminate the possibility that this affected
membrane permeability we also used a mixture of mitochondrial
inhibitors to abolish the mitochondrial membrane potential.
For 12 and 18 (Figures 7E,F) and 14, 16 (data not shown) there
was similar loss of the acid upon abolition of the membrane
potential as was found with FCCP. Finally, to assess how quickly
the acid left mitochondria upon uncoupling we incubated
mitochondria with 14 for 5min, then added FCCP and then
isolated mitochondria at various time points subsequently
(Figure 7G). The rate of efflux of the acid was indistinguishable
from that of the IS and the ester at the earliest time point
accessible in this experiment (Figure 7G). We conclude that
these acids rapidly efflux from mitochondria upon loss of the
membrane potential.
To see if the acids were retained within mitochondria by
a membrane potential we next assessed their retention over
time. When mitochondria were incubated with 13, 17 and
19, for up to 15min IS accumulation was constant, but the
amount of the acid present within mitochondria decreased over
time (Figures 7H,I,J), with similar data for esters 12, 13, 16,
and 18 (data not shown). To further confirm that acids are
lost from energized mitochondria, we incubated mitochondria
with 18 for 5min, and then pelleted the mitochondria and
resuspended in fresh incubation medium. The IS was retained
by the resuspended mitochondria while the acid was lost
(Figure 7K). We conclude that the acids are rapidly lost from
energized mitochondria.
The acids 3–8 are not taken up by energized mitochondria,
but when generated within mitochondria they are not retained,
whether or not there is a membrane potential. One possibility
is that the acid can cross the membrane as both the protonated
cation and also as the neutral zwitterion. Thus, membrane
potential driven uptake of the acids 3–8 in their cationic
protonated form, followed by deprotonation and loss of the
zwitterion might explain the lack of accumulation. However, this
would involve a net influx of protons into the mitochondrial
matrix and consequent mitochondrial uncoupling. As increased
mitochondrial oxygen consumption is diagnostic of such
uncoupling, we measured the effect on this of 3, 4, 6, and
7, compared to corresponding methyl or hexyl TPPs controls
(Figures 8A,B). In all cases the effect of the acid on oxygen
consumption was lower than the control compound, which
showed themild uncoupling expected for TPP-compounds (Reily
et al., 2013). We conclude that our data cannot be explained by
the acids entering as a cation and leaching out as the neutral
zwitterion, unless the membrane potential-driven uptake of the
cation is very slow and matched by the efflux of the zwitterion
(Figure 8A).
Computational Analysis of Membrane
Transport by TPP Derivatives
Low-pKa TPP-carboxylic acids are not accumulated by energized
mitochondria. It is probable that the protonated cation can
cross membranes in response to the membrane potential, but
that the low concentration of this species renders the flux
negligible compared to efflux pathway(s). Once generated within
the mitochondrial matrix, the acids are rapidly lost. As this efflux
is unaffected by the membrane potential, the acid must cross the
membrane as a neutral species. To explore how this might occur
we next carried out computational studies to evaluate the Gibbs
free energy of membrane crossing of simple salts of TPMP and
some of the acids.
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FIGURE 6 | Mitochondrial uptake and hydrolysis of esters. (A) Structures of ethyl esters 12–15 of TPP carboxylic acids. (B–E) Quantification of mitochondrial uptake
of 12–15. Liver mitochondria were incubated as described in Figure 2B. (B), 12, IS =isoamylTPP; (C), 13, IS = TPMP; (D), 14, IS = isoamylTPP; (E), 15, IS =TPMP.
(F) Structures of trifluoroethyl esters 16–19 of TPP carboxylic acids. (G–J) Liver mitochondria were incubated and analyzed with esters as described in Figure 2B. (G),
16, IS =isoamylTPP; (H), 17, IS = TPMP; (I), 18, IS = TPMP; (J), 19, IS =TPMP. (K–M) Heart mitochondria incubated as described in Figure 2B with 12, 16 or 18 ±
FCCP. (K), 12, IS = isoamylTPP; (L), 16, IS = isoamylTPP; (M), 18, IS = isoamylTPP. Data are mean ± S.E.M. of RP-HPLC peak areas from three biological replicates.
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FIGURE 7 | Assessment of retention of acids within mitochondria. Liver (A,B,E,F) or heart (C,D) mitochondria were incubated with 12 or 18 as described in
Figure 2B for 5min and then either incubated for a further 5min and then pelleted, or FCCP (B,D) was added and after 5min further incubation the mitochondria
were then pelleted. (A), 12, IS = isoamylTPP; (B), 18, IS = isoamyl TPP; (C), 12, IS = isoamyl TPP; (D), 18, IS = isoamyl TPP. (E,F) Liver mitochondria were
incubated as described in Figure 2B for 5min with esters (E), 12 IS = isoamylTPP, or [(F), 18 IS = TPMP] for 10min ± a mixture of oligomycin/antimycin
A/valinomycin or were incubated for 5min and then a mixture of oligomycin/antimycin A/valinomycin was added after 5min incubation followed by 5min further
incubation. (G), Liver mitochondria were incubated with 14 and isoamyl TPP as an IS for 5min, then FCCP was added and the uptake into mitochondria analyzed at
the indicated times. (H,I) Liver mitochondria were incubated as described in Figure 2B with the esters 17–19 for various times and the amounts within the
mitochondria were analyzed. (H), 13, IS = TPMP; (I), 17, IS = TPMP; (J), 19, IS = TPMP. (K) Liver mitochondria were incubated with 18 and IS = isoamyl TPP for
5min. Mitochondria were then pelleted by centrifugation and resuspended for 5 or 10min and then pelleted again. Data are presented as mean ± S.E.M. of quantified
peak areas from three biological replicates.
The thermodynamics of transfer of ions through, or
their partitioning into, a phospholipid membrane can be
approximated by considering the transfer of ions from aqueous
solution to an apolar medium that mimics the hydrophobic
membrane core; here, we chose hexane as the apolar medium.
We have used this model previously in calculations to explain
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FIGURE 8 | Lack of mitochondrial uncoupling by TPP acids. (A,B) Liver mitochondria (0.25mg mitochondrial protein/mL) respiring on succinate were incubated in
KCl buffer (pH 7.2, 37◦C) were in an Oroboros O2K high resolution respirometer A range of concentrations of 3, 4, 6, or 7, or of appropriate ISs, were incubated and
the effect on respiration rate, relative to controls without additions were determined. Data are percentage of initial respiration rate before addition of test compounds
and are mean ± S.E.M. of three biological replicates.
differences in the behavior of cations crossing membranes
and accumulating in response to a membrane potential (Robb
et al., 2015). It has since received some experimental validation,
when (Rokitskaya et al., 2019) showed that calculations on
partitioning into an alkane solvent correlate exceptionally well
with experiments on transmembrane movement of lipophilic
ions across black lipid membranes. The ion can transfer from
water to hexane as a free ion, or together with a counter-ion such
as Cl− as a charge-neutral ion pair. For the transfer of a single
monovalent cation from water to hexane, we write
M+(aq)+ X−(aq)→ M+(Hex)+ X−(aq) (1)
The biologically relevant counter-anions X− are typically small
and strongly hydrophilic, so their partitioning into the apolar
phase is negligible and is only shown here to facilitate comparison
with the transfer of an ion pair, as is discussed below. The cation is
sufficiently lipophilic to transfer to the apolar phase. The change
in free energy associated with Equation (1) is therefore the single-
ion free energy of transfer, 1tG∗(M+, aq→ Hex). The transfer
free energy of a solute S is defined as the difference in solvation
energy of S between the two solvents:
1tG
∗(S, aq→ Hex) = 1solvG
∗(S, Hex)−1solvG
∗(S, aq)
If we start from the same initial state of free solvated ions, the
transfer of a neutral ion pair (IP) contains two components:
firstly, the formation of the IP in water and secondly, the transfer
of the IP to the apolar phase.
M+(aq)+ X−(aq)→ [M+·X−](aq)→ [M+·X−](Hex) (2)
Accordingly, the free-energy change associated with Equation (2)
is the sum of the free energies of ion-pairing and of transfer of the
Frontiers in Chemistry | www.frontiersin.org 12 September 2020 | Volume 8 | Article 783
Pala et al. Enhancing Mitochondrial Uptake of Cations
ion pair.
1ipG
∗(aq)+1tG
∗(IP, aq→ Hex)
Depending on how well solvated the ion is in the respective
phase and the stability of the ion pair, it will be more
thermodynamically favorable for an ion to cross either as a free
ion (Equation 1) or as an ion pair (Equation 2).
Consider TPMP+ (Ph3PMe+) and its ion pair with chloride,
[TPMP+ · Cl−]: Table 2 lists the calculated free energies of
transfer for the free ion and the ion pair; for the ion pair, the
free energy of pairing is given together with the sum of pairing
+ transfer of the pair, which is the relevant free energy for
crossing as a pair. Unsurprisingly, the free TPMP+ cation is
better solvated in water than in hexane, making the transfer
from water to hexane thermodynamically unfavorable, albeit far
less so than for small ions with localized, concentrated charge,
such as Na+. Larger ions, such as TPMP+, have smaller surface
charge densities and expose apolar surface patches to the solvent.
Hence, they are relatively less well stabilized in water and so
the difference between stabilization in the aqueous phase and
stabilization by favorable apolar interactions in hexane is less,
and the energy cost of transfer from water to hexane is lower
(Reichardt and Welton, 2011).
Despite any free ion being strongly solvated in water, the
formation of ion pairs in water is only relatively weakly
endergonic. All the ion pairs considered here are still more
stable in water than in hexane, but their transfer free
energies are smaller than for ions in many cases. Generally
speaking, the more hydrophilic/polar the free ion is, the
more it benefits from ion-pairing in terms of reducing the
energetic disadvantage associated with transferring to hexane.
For the example of TPMP+, it transfers relatively easily as
a free cation; the transfer as an ion-pair [TPMP+ · Cl−] is
disfavoured by another 14 kJ mol−1. In summary, “lipophilic”
ions (low overall charge, small surface charge, large apolar
surface patches) can transfer as free ions from water to
hexane at modest thermodynamic cost. They do not benefit
from ion-pairing. On the other hand, for hydrophilic ions
(high overall charge, concentrated surface charge, little apolar
surface area), it is thermodynamically prohibitive to transfer as
free ions. However, when paired with a strongly hydrophilic
counter ion the cost of transferring is significantly reduced
(Robb et al., 2015).
We now consider derivatives of TPMP+ where one of the
phenyl rings has been substituted in para position with a
carboxyl or carboxymethyl group. There are therefore multiple
possibilities of forming ion pairs with counter-anions or cations
(Table 2). Comparing the transfer free energies of the single
species, TPMP+, TPMP+-COOH, and TPMP+-COO−, it can
be seen that introducing the neutral, protonated carboxyl group
makes the transfer∼20 kJ mol−1 more unfavorable (compared to
unsubstituted TPMP+) (Table 2). Transferring the zwitterionic
carboxylate is significantly disfavored (by ∼40 kJ mol−1)
despite the overall neutral charge because the negative charge
of the carboxylate is solvent-exposed and relatively localized.
Depending on whether the carboxylic acid is deprotonated or
neutral, the following ion pairs were considered: [TPMP+-
COOH · Cl−], [TPMP+-COO− · Cl−]−, [TPMP+-COO− ·
Na+]+. None of these ion pairs transfers more easily than the
corresponding single species (Table 2).
However, the zwitterions TPMP+-COO− and TPMP+-
CH2COO− have the ability to form self-complementary (“head-
to-tail”) dimers (Figure 9). In these structures, the negatively
TABLE 2 | Calculated free energies of transfer of solute S from water to hexane, 1tG
*(S, aq→ Hex), and free energies of ion-pairing in water, 1ipG
*(aq).
Solute S 1tG*(S, aq→ Hex) 1ipG*(aq) 1ipG*(aq) + 1tG*(S, aq→ Hex) Ion-pair preference
TPMP+ 44
TPMP+-COOH 64
TPMP+-COO− 86
TPMP+-CH2COOH 59
TPMP+-CH2COO
− 88
Cl− 157
Na+ 229
TPMP+ · Cl− 39 19 58 14
TPMP+-COOH · Cl− 55 18 73 9
TPMP+-COO− · Cl− 160 19 179 93
TPMP+-COO− · Na+ 126 −3 123 40
TPMP+-COO−2
a 39 16 55 −30
TPMP+-CH2COO
−
2 (Conf 1)
a 16 34 50 −39
TPMP+-CH2COO
−
2 (Conf 2)
a 30 12 41 −47
All free energies are in kJ mol−1.
The preference for crossing as ion pair is defined as 1ipG*(aq) + 1tG*(IP, aq→ Hex) – 1tG*(free ion, aq→ Hex); a negative value means that crossing as an ion pair is preferred to
crossing as a free ion. The term “ion-pairing” is used here to designate both the association with a small counter-ion and the dimerisation of zwitterions.
aEnergies are per mol of monomer.
Comparable values for the transfer of free ions vs. ion-pairs are highlighted in bold.
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FIGURE 9 | Optimized structures of self-complementary dimers of the assessed zwitterions in water and hexane.
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FIGURE 10 | (A) The X-ray crystal structure of [TPMP+-COOH · I− ] with atomic displacement ellipsoids drawn at 50% probability level for non-hydrogen atoms. (B)
The X-ray crystal structure of TPMP+-COO− with atomic displacement ellipsoids drawn at 50% probability level for non-hydrogen atoms. (C) View of the Hirshfeld
surface of TPMP+-COO− mapped with dnorm property (calculated using CrystalExplorer), contact distance < van der Waals contact are shown in red, equal to it in
white and longer as blue. (Spackman and Jayatilaka, 2009).
charged carboxylate groups are partially buried within the
pocket formed by the α- and β-hydrogens of the methyl and
phenyl substituents of the phosphonium, respectively, which
carry a significant fraction of the positive charge (Figure 9).
These stabilizing electrostatic interactions make the dimer
formation in water similarly favorable to ion-pairing with a
small single ion like Cl−, that is, endergonic by ∼15–20 kJ
mol−1. At the same time, in the dimers, the negative charges
of the carboxylates are locally compensated for and partially
shielded from the solvent so that there is less stabilization
from interactions with water. Therefore, transfer to hexane is
less unfavorable than for the single zwitterions. For the dimer
[TPMP+-CH2COO−]2, we considered two minimum energy
structures. Conformer 2 is more stable than Conformer 1 by
45 kJ mol−1 in water, but only by 17 kJ mol−1 in hexane.
Dimerisation in water is therefore more favorable for Conformer
2, but the transfer energy is less endergonic for Confomer 1 (see
Table 2). The two effects largely compensate each other, such that
transferring as dimers is clearly preferred for both conformers.
Overall, therefore, the dimers transfer significantly more easily
than the corresponding single species. The calculated Gibbs
energies for all the species taken into consideration (cations,
ion pairs, and dimers) are reported in Table 2. We conclude
that the most likely way in which the TPP acid derivatives can
leave mitochondria is as a neutral dimer of two zwitterionic
molecules (Figure 9).
X-ray Crystallography Support for Dimers
Finally, we sought crystallographic evidence of the benefit
of the interactions identified in our models of the dimer
[TPMP+-COO−]2. To do this, we synthesized the pure
zwitterionic species without any counterion. First, the iodide
salt was prepared by the method used to make the chloride
salt 3 of the carboxylic acid (Scheme 1), but without ion
exchange. Single crystals of this compound, [TPMP+-COOH
· I−], were grown. Treatment of the iodide salt with silver
carbonate removed the iodide and allowed single crystals of the
zwitterion, TPMP+-COO−, also to be grown. Single crystal X-
ray diffraction revealed the structures of both [TPMP+-COOH
· I−] and TPMP+-COO− (Figures 10A,B). [TPMP+-COOH
· I−] has a C–OH length of 1.325(2) Å and a C=O length
of 1.204(2) Å, which are close to the typical C–O (1.308 Å)
and C=O (1.214 Å) bond lengths in carboxylic acids (Allen
et al., 2006). As expected, there is no halogen present in the
structure of TPMP+-COO− with the positive charge of the
phosphonium ions balanced in the crystal by the negatively
charged carboxylate ions. The C–O bond lengths of 1.233(3)
and 1.246(3) Å match closely the typical bond length of
1.254 Å for a delocalised C=O carboxylate bond (Allen et al.,
2006). Within the crystal lattice multiple individual molecules
interact to satisfy the attractive electrostatic interactions in
a range of packing motifs. Among these, evidence for the
proposed “head-to-tail” dimers was observed (Figure 10C).
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FIGURE 11 | Model explaining the behavior of the esters 12–19 within mitochondria. Lipophilic cations of esters 12–19 cross the mitochondrial inner membrane and
accumulate several hundred-fold due to membrane potential. Hydrolysis forms the cations of carboxylic acids 3, 4, 6, and 7 which exist almost exclusively as their
highly charged zwitterions at pH 8.0. Two molecules of the zwitterions dimerise forming an ion couple that diffuses out driven by the concentration gradient created by
accumulation of the esters 12–19 and then dissociate. IMM, inner mitochondrial membrane; IMS, intermembrane space.
Here, the carboxylate group of one molecule is in close
proximity to the α-hydrogen of the methyl (2.440 Å) and the β-
hydrogen of the phenyl (2.237 Å) of its neighbor’s phosphonium
group. These distances agree well with those predicted in
our theoretical models of the dimer [TPMP+-CH2COO−]2
(Figure 9).
CONCLUSION
We set out to develop a mitochondria-targeting strategy that
would enhance uptake into mitochondria using a targeting head
group that would increase mitochondrial uptake of simple TPP
cations by responding not only to the membrane potential
but also to the pH gradient across the mitochondrial inner
membrane. Here we show that incorporation of a propionic
acid into a TPP moiety provides derivatives that accumulate
in response to both these factors, albeit with a lower ACR
than simple TPP compounds. On the other hand, we found
that TPP moieties derivatised with benzoic or phenylacetic
acid groups on the phosphonium were not taken up by
mitochondria due to the low pKa of these acids depleting
the amount of cation available to cross the membrane. This
suggested that this finding could be exploited to generate esters
that would generate such membrane impermeant acids within
the mitochondrial matrix thereby locking molecules within
the mitochondrial matrix. As the ability to lock molecules
within mitochondria might facilitate the development of more
persistent mitochondrial probes and therapies, we explored this
possibility. To our surprise, we found that despite their low pKa
these acids were rapidly lost from mitochondria, irrespective
of the presence of a membrane potential. A computational
approach suggested that this occurred by the zwitterions forming
dimers and that these neutral dimers were then able to pass
through the mitochondrial inner membrane. Thus, esters 12–
19 accumulate in the matrix driven by the membrane potential,
but upon hydrolysis, the corresponding carboxylic acids 3, 4,
6, and 7 are not trapped (Figure 11). Instead, they diffuse out
of the matrix as dimers of their zwitterions, driven by the
concentration gradient. Our work suggests that making TPP
carboxylic compounds in which the ability to form dimers
was prevented (e.g., by incorporating bulky groups) would
improve delivery and open up a new mitochondrial lock
in strategy.
In summary, by investigating methods to enhance TPP
delivery to mitochondria we have revealed the factors that
govern uptake of TPP-carboxylic acids and exposed new potential
strategies, which we will explore in future work.
DATA AVAILABILITY STATEMENT
The NMR data, the Fourier transformed NMR spectra for the
synthesised compounds and xyz coordinates and energies of all
optimised structures can be found in the University of Glasgow
repository http://dx.doi.org/10.5525/gla.researchdata.1004. The
Frontiers in Chemistry | www.frontiersin.org 16 September 2020 | Volume 8 | Article 783
Pala et al. Enhancing Mitochondrial Uptake of Cations
CIF files CCDC 1998454 [TPMP+-COO−] and 1998455
(TPMP+-COOH.I−] contain the supplementary crystallographic
data for this paper. These data can be obtained free of charge from
The Cambridge Crystallographic Data Centre via www.ccdc.cam.
ac.uk/structure.
ETHICS STATEMENT
All experiments were conducted according to the Animals
Scientific Procedures Act 1986 (UK) and directive 2010/63/EU of
the European Parliament guidelines on the protection of animals
used for scientific purposes. All experiments were approved by
the University of Cambridge Institutional Animal Welfare and
Ethical Review Body.
AUTHOR CONTRIBUTIONS
LP synthesized the majority of the compounds and carried
out most biological testing. HS carried out the computational
calculations. SC synthesized some of the compounds. SW and
CW carried out and interpreted the single X-ray crystallography
study. TP and TB carried out biological testing. HP helped design
of biological experiments. RH and MM supervised the project
and the manuscript writing. All authors contributed to the article
and approved the submitted version.
FUNDING
Work in the MM laboratory was supported by the Medical
Research Council UK (MC_U105663142) and by a Wellcome
Trust Investigator award (110159/A/15/Z). Work in the RH
laboratory was supported by a Wellcome Trust Investigator
award (WT110158/Z/15/Z) and LP was supported by a
studentship from the University of Glasgow.
ACKNOWLEDGMENTS
HS is grateful to Kristia¯ns Cˇern¸evicˇs for performing some of
the calculations reported here as part of his MSci thesis at the
University of Glasgow.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: https://www.frontiersin.org/articles/10.3389/fchem.
2020.00783/full#supplementary-material
REFERENCES
Ahlrichs, R., Bär, M., Häser, M., Horn, H., and Kölmel, C. (1989). Electronic
structure calculations on workstation computers: the program system
turbomole. Chem. Phys. Lett. 162, 165–169. doi: 10.1016/0009-2614(89)
85118-8
Alecu, I. M., Zheng, J., Zhao, Y., and Truhlar, D. G. (2010). Computational
thermochemistry: scale factor databases and scale factors for vibrational
frequencies obtained from electronic model chemistries. J. Chem. Theory
Comput. 6, 2872–2887. doi: 10.1021/ct100326h
Allen, F. H., Watson, D. G., Brammer, L., Orpen, A. G., and Taylor, R. (2006).
Typical interatomic distances: organic compounds. Int. Tables Crystallog. C 9,
790–811. doi: 10.1107/9780955360206000062
Barton, P., Laws, A. P., and Page, M. I. (1994). Structure-activity relationships in
the esterase-catalysed hydrolysis and transesterification of esters and lactones.
J. Chem. Soc, Perkin Trans. 2, 2021–2029. doi: 10.1039/P29940002021
Ben-Naim, A. (1987). Solvation Thermodynamics. New York, NY: Plenum Press.
Ben-Naim, A. (1992). Statistical Thermodynamics for Chemists and Biochemists.
New York, NY: Plenum Press.
Chappell, J. B., and Hansford, R. G. (1972). “Preparation of mitochondria
from animal tissues and yeasts,” in Subcellular Components: Preparation and
Fractionation, ed. G. Birnie (London: Butterworths), 77–91.
Dydio, P., Detz, R. J., de Bruin, B., and Reek, J. N. (2014). Beyond classical reactivity
patterns: hydroformylation of vinyl and allyl arenes to valuable beta- and
gamma-aldehyde intermediates using supramolecular catalysis. J. Am. Chem.
Soc. 136, 8418–8429. doi: 10.1021/ja503033q
Finichiu, P. G., James, A. M., Larsen, L., Smith, R. A., and Murphy, M. P. (2013).
Mitochondrial accumulation of a lipophilic cation conjugated to an ionisable
group depends on membrane potential, pH gradient and pKa: implications for
the design of mitochondrial probes and therapies. J. Bioenerg. Biomembr. 45,
165–173. doi: 10.1007/s10863-012-9493-5
Finichiu, P. G., Larsen, D. S., Evans, C., Larsen, L., Bright, T. P., Robb, E. L., et al.
(2015). A mitochondria-targeted derivative of ascorbate: MitoC. Free Radic.
Biol. Med. 89, 668–678. doi: 10.1016/j.freeradbiomed.2015.07.160
Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., and
Cheeseman, J. R. (2013). Gaussian 09. Version Revision E.01. Wallingford, CT:
Gaussian, Inc.
Funes-Ardoiz, I., and Paton, R. S. (2018). GoodVibes V. 2.0.3.
doi: 10.5281/zenodo.1435820
Gorman, G. S., Chinnery, P. F., DiMauro, S., Hirano, M., Koga, Y., McFarland,
R., et al. (2016). Mitochondrial diseases. Nat. Rev. Dis. Primers. 2:16080.
doi: 10.1038/nrdp.2016.80
Grimme, S., Antony, J., Ehrlich, S., and Krieg, H. (2010). A consistent and accurate
ab initio parametrization of density functional dispersion correction (DFT-D)
for the 94 elements H–Pu. J. Chem. Phys. 132:154104. doi: 10.1063/1.3382344
Grimme, S., Ehrlich, S., and Goerigk, L. (2011). Effect of the damping function
in dispersion corrected density functional theory. J. Comput. Chem. 32,
1456–1465. doi: 10.1002/jcc.21759
Häser, M., and Ahlrichs, R. (1989). Improvements on the direct SCF method. J.
Comput. Chem. 10, 104–111. doi: 10.1002/jcc.540100111
Hu, Z., Sim, Y., Kon, O. L., Ng, W. H., Ribeiro, A. J., Ramos, M.
J., et al. (2017). Unique triphenylphosphonium derivatives for enhanced
mitochondrial uptake and photodynamic therapy. Bioconjugate Chem. 28,
590–599. doi: 10.1021/acs.bioconjchem.6b00682
Hünenberger, P., and Reif, M. (2011). Single-Ion Solvation: Experimental and
Theoretical Approaches to Elusive Thermodynamic Quantities. London: Royal
Society of Chemistry.
Jean, S. R., Ahmed, M., Lei, E. K., Wisnovsky, S. P., and Kelley,
S. O. (2016). Peptide-mediated delivery of chemical probes and
therapeutics to mitochondria. Acc. Chem. Res. 49, 1893–1902.
doi: 10.1021/acs.accounts.6b00277
Kanchanakungwankul, S., Bao, J. L., Zheng, J., Alecu, I. M., Lynch, B. J.,
Zhao, Y., et al. (2018). Database of Frequency Scale Factors for Electronic
Model Chemistries. 4th Edn. Available online at: https://comp.chem.umn.edu/
freqscale/
Kanicky, J. R., and Shah, D. O. (2003). Effect of premicellar aggregation on the pKa
of fatty acid soap solutions. Langmuir 19, 2034–2038. doi: 10.1021/la020672y
Klamt, A. (1996). Calculation of UV/Vis spectra in solution. J. Phys. Chem. 100,
3349–3353. doi: 10.1021/jp950607f
Klamt, A., and Jonas, V. (1996). Treatment of the outlying charge in continuum
solvation models. J. Chem. Phys. 105, 9972–9981. doi: 10.1063/1.472829
Klamt, A., and Schüürmann, G. (1993). COSMO–A new approach to dielectric
screening in solvents with explicit expressions for the screening energy and its
gradient. J. Chem. Soc. Perkin Trans. 2, 799–805. doi: 10.1039/P29930000799
Frontiers in Chemistry | www.frontiersin.org 17 September 2020 | Volume 8 | Article 783
Pala et al. Enhancing Mitochondrial Uptake of Cations
Logan, A., Cocheme, H. M., Li Pun, P. B., Apostolova, N., Smith, R. A., Larsen, L.,
et al. (2014). Using exomarkers to assess mitochondrial reactive species in vivo.
Biochim. Biophys. Acta 1840, 923–930. doi: 10.1016/j.bbagen.2013.05.026
Marenich, A. V., Cramer, C. J., and Truhlar, D. G. (2009). Universal solvation
model based on solute electron density and on a continuum model of the
solvent defined by the bulk dielectric constant and atomic surface tensions. J.
Phys. Chem. B 113, 6378–6396. doi: 10.1021/jp810292n
Murphy, M. P., and Hartley, R. C. (2018). Mitochondria as a therapeutic
target for common pathologies. Nat. Rev. Drug Discov. 17, 865–886.
doi: 10.1038/nrd.2018.174
Nicholls, D. G., and Ferguson, S. J. (2013). Bioenergetics 4. London:
Academic Press.
Nunnari, J., and Suomalainen, A. (2012). Mitochondria: in sickness and in health.
Cell 148, 1145–1159. doi: 10.1016/j.cell.2012.02.035
Qin, L., Hu, B., Neumann, K. D., Linstad, E. J., McCauley, K., Veness,
J., et al. (2015). A mild and general one-pot synthesis of densely
functionalized diaryliodonium salts. Eur. J. Org. Chem. 2015, 5919–5924.
doi: 10.1002/ejoc.201500986
Reichardt, C., and Welton, T. (2011). Solvents and Solvent Effects in Organic
Chemistry, 4th Edn. Weinheim: Wiley-VCH.
Reily, C., Mitchell, T., Chacko, B. K., Benavides, G. A., Murphy, M. P., and Darley-
Usmar, V. M. (2013). Mitochondrially targeted compounds and their impact
on cellular bioenergetics. Redox Biol. 1, 86–93. doi: 10.1016/j.redox.2012.
11.009
Ribeiro, R. F., Marenich, A. V., Cramer, C. J., and Truhlar, D. G. (2011). Use
of solution-phase vibrational frequencies in continuum models for the free
energy of solvation. J. Phys. Chem. B. 115, 14556–14562. doi: 10.1021/jp2
05508z
Robb, E. L., Gawel, J. M., Aksentijevic, D., Cocheme, H. M., Stewart, T. S.,
Shchepinova, M. M., et al. (2015). Selective superoxide generation within
mitochondria by the targeted redox cycler MitoParaquat. Free Radic. Biol. Med.
89, 883–894. doi: 10.1016/j.freeradbiomed.2015.08.021
Rokitskaya, T. I., Luzhkov, V. B., Korshunova, G. A., Tashlitsky, V. N., and
Antonenko, Y. N. (2019). Effect of methyl and halogen substituents on the
transmembrane movement of lipophilic ions. Phys. Chem. Chem. Phys. 21,
23355–23363. doi: 10.1039/c9cp03460a
Ross, M. F., Da Ros, T., Blaikie, F. H., Prime, T. A., Porteous, C. M., Severina, I.
I., et al. (2006). Accumulation of lipophilic dications by mitochondria and cells.
Biochem. J. 400, 199–208. doi: 10.1042/BJ20060919
Rumble, J. R., Lide, D. R., Bruno, T. J. (eds.) (2018). CRC Handbook of Chemistry
and Physics. 99th edn. Boca Raton, FL: CRC Press.
Sierka, M., Hogekamp, A., and Ahlrichs, R. (2003). Fast evaluation of the
Coulomb potential for electron densities using multipole accelerated resolution
of identity approximation. J. Chem. Phys. 118, 9136–9148. doi: 10.1063/1.15
67253
Smith, R. A., Hartley, R. C., Cocheme, H. M., and Murphy, M. P.
(2012). Mitochondrial pharmacology. Trends Pharmacol. Sci. 33, 341–352.
doi: 10.1016/j.tips.2012.03.010
Smith, R. A., Hartley, R. C., and Murphy, M. P. (2011). Mitochondria-targeted
small molecule therapeutics and probes. Antioxid. Redox Sign. 15, 3021–3038.
doi: 10.1089/ars.2011.3969
Smith, R. A., Porteous, C. M., Gane, A. M., and Murphy, M. P. (2003). Delivery of
bioactive molecules to mitochondria in vivo. Proc. Natl. Acad. Sci. U.S.A. 100,
5407–5412. doi: 10.1073/pnas.0931245100
Spackman, M. A., and Jayatilaka, D. (2009). Hirshfeld surface analysis Cryst. Eng.
Comm. 11, 19–32. doi: 10.1039/B818330A
Tao, J. M., Perdew, J. P., Staroverov, V. N., and Scuseria, G. E. (2003).
Climbing the density functional ladder: nonempirical meta-generalized
gradient approximation designed for molecules and solids. Phys. Rev. Lett. 91,
146401. doi: 10.1103/PhysRevLett.91.146401
Tomasi, J., Mennucci, B., and Cammi, R. (2005). Quantummechanical continuum
solvation models. Chem. Rev. 105, 2999–3093. doi: 10.1021/cr9904009
Treutler, O., and Ahlrichs, R. (1995). Efficient molecular numerical integration
schemes. J. Chem. Phys. 102, 346–354. doi: 10.1063/1.469408
von Arnim, M., and Ahlrichs, R. (1998). Performance of parallel Turbomole
for density functional calculations. J. Comput. Chem. 19, 1746–1757.
doi: 10.1002/(SICI)1096-987X(19981130)19:15<1746::AID-JCC7>3.0.
CO;2-N
von Arnim, M., and Ahlrichs, R. (1999). Geometry optimization in
generalized natural internal coordinates. J. Chem. Phys. 111, 9183–9190.
doi: 10.1063/1.479510
Weigend, F. (2006). Accurate Coulomb-fitting basis sets for H to Rn. Phys. Chem.
Chem. Phys. 8, 1057–1065. doi: 10.1039/B515623H
Weigend, F., and Ahlrichs, R. (2005). Balanced basis sets of split valence, triple zeta
valence and quadruple zeta valence quality for H to Rn: design and assessment
of accuracy. Phys. Chem. Chem. Phys. 7, 3297–3305. doi: 10.1039/B508541A
Yousif, L. F., Stewart, K. M., and Kelley, S. O. (2009). Targeting mitochondria
with organelle-specific compounds: strategies and applications. Chembiochem
10, 1939–1950. doi: 10.1002/cbic.200900185
Zhao, Y., and Truhlar, D. G. (2008). The M06 suite of density functionals for main
group thermochemistry, thermochemical kinetics, noncovalent interactions,
excited states, and transition elements: two new functionals and systematic
testing of four M06-class functionals and 12 other functionals. Theor. Chem.
Acc. 120, 215–241. doi: 10.1007/s00214-007-0310-x
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Pala, Senn, Caldwell, Prime, Warrington, Bright, Prag, Wilson,
Murphy and Hartley. This is an open-access article distributed under the terms
of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) and the
copyright owner(s) are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Chemistry | www.frontiersin.org 18 September 2020 | Volume 8 | Article 783
